We provide you with 20 years of free, institutional-grade data for ALPN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALPN. Explore the full financial landscape of ALPN stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2024-05-09 | 1626199 | ALPN | 10-Q | Url |
2024-03-20 | 1626199 | ALPN | 10-K | Url |
2023-11-14 | 1626199 | ALPN | 10-Q | Url |
2023-08-14 | 1626199 | ALPN | 10-Q | Url |
2023-05-11 | 1626199 | ALPN | 10-Q | Url |
2023-03-23 | 1626199 | ALPN | 10-K | Url |
2022-11-14 | 1626199 | ALPN | 10-Q | Url |
2022-08-11 | 1626199 | ALPN | 10-Q | Url |
2022-05-12 | 1626199 | ALPN | 10-Q | Url |
2022-03-17 | 1626199 | ALPN | 10-K | Url |
2021-11-10 | 1626199 | ALPN | 10-Q | Url |
2021-08-10 | 1626199 | ALPN | 10-Q | Url |
2021-05-13 | 1626199 | ALPN | 10-Q | Url |
2021-03-18 | 1626199 | ALPN | 10-K | Url |
2020-11-12 | 1626199 | ALPN | 10-Q | Url |
2020-08-11 | 1626199 | ALPN | 10-Q | Url |
2020-08-11 | 1626199 | ALPN | S-1 | Url |
2020-05-14 | 1626199 | ALPN | 10-Q | Url |
2020-03-30 | 1626199 | ALPN | 10-K | Url |
2019-11-14 | 1626199 | ALPN | 10-Q | Url |
2019-08-13 | 1626199 | ALPN | 10-Q | Url |
2019-05-09 | 1626199 | ALPN | 10-Q | Url |
2019-03-18 | 1626199 | ALPN | 10-K | Url |
2019-03-18 | 1626199 | ALPN | S-1 | Url |
2018-11-08 | 1626199 | ALPN | 10-Q | Url |
2018-08-09 | 1626199 | ALPN | 10-Q | Url |
2018-05-14 | 1626199 | ALPN | 10-Q | Url |
2018-03-28 | 1626199 | ALPN | 10-K | Url |
2017-11-14 | 1626199 | ALPN | 10-Q | Url |
2017-07-21 | 1626199 | ALPN | 10-Q | Url |
2017-05-02 | 1626199 | ALPN | 10-Q | Url |
2017-02-13 | 1626199 | ALPN | 10-K | Url |
2016-11-07 | 1626199 | ALPN | 10-Q | Url |
2016-08-02 | 1626199 | ALPN | 10-Q | Url |
2016-05-03 | 1626199 | ALPN | 10-Q | Url |
2016-03-08 | 1626199 | ALPN | 10-K | Url |
2015-11-03 | 1626199 | ALPN | 10-Q | Url |
2015-08-04 | 1626199 | ALPN | 10-Q | Url |
2015-05-13 | 1626199 | ALPN | S-1 | Url |
Alpine Immune Sciences, Inc(NASDAQ:ALPN)


Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline include ALPN-101, an inducible T cell costimula...
Website: http://www.alpineimmunesciences.com
Founded: 2007
Full Time Employees: 53
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ALPN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.